Тематические порталы ИД "Русский врач": Кардиология, Педиатрия
 
     



Мероприятия

 

Фармакотерапия биполярного аффективного расстройства во время беременности и в послеродовом периоде

magazine-vrach-2012-08-004

Фармакотерапия биполярного аффективного расстройства во время беременности и в послеродовом периоде

Отмена при биполярном аффективном расстройстве (БАР) фармакотерапии во время беременности повышает риск развития рецидивов. Приводятся сведения о безопасности лекарственных средств, применяемых для лечения БАР в период гестации и кормления грудью, а также современные рекомендации по ведению беременных с БАР.
Pharmacotherapy for bipolar affective disorder during pregnancy and postpartum
The paper analyzes data on bipolar affective disorders (BAD) in which pharmacotherapy discontinuation during pregnancy increases the risk of recurrences. It gives information on the safety of drugs used to treat BAD during gestation and lactation, as well as current guidelines for the management of pregnant women with BAD.

Литература

1. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision) // Am. J. Psychiatry. – 2002; 159: 1–50.
2. Armstrong C. ACOG Guidelines on Psychiatric Medication Use During Pregnancy and Lactation Practice Guidelines // Am. Fam. Physician. – 2008; 15; 78 (6): 772–8.
3. Austin M. Puerperal affective psychosis: is there a case for lithium prophylaxis? // Br. J. Psychiatry. – 1992; 161: 692–4.
4. Bergink V., Bouvy P., Vervoort J. et al. Prevention of postpartum psychosis and mania in women at high risk // Am. J. Psychiatry. – 2012; 169 (6): 609–15.
5. Bhattacharya A. Khess C., Munda S. et al. Sex difference in symptomatology of manic episode // Compr. Psychiatry. – 2011; 52 (3): 288–92.
6. Birnbaum C., Cohen L., Bailey J. et al. Serum concentrations of antidepressants and benzodiazepines in nursing infants. A case series // Pediatrics. – 1999; 104: e11.
7. Bonari L., Pinto N., Ahn E. et al. Perinatal risks of untreated depression during pregnancy // Can. J. Psychiatry. – 2004; 49 (11): 726–35.
8. Burt V., Rasgon N. Special considerations in treating bipolar disorder in women // Bipolar Disord. – 2004; 6: 2–13, 271.
9. Cohen L., Friedman J., Jefferson J. et al. A reevaluation of risk of in utero exposure to lithium // JAMA. – 1994; 271: 146–50.
10. Cohen L., Sichel D., Robertson L. et al. Postpartum prophylaxis for women with bipolar disorder // Am. J. Psychiatry. – 1995; 152: 1641–5.
11. Crawford P. Interactions between antiepileptic drugs and hormonal contraception // CNS Drugs. – 2002; 16: 263–72.
12. Curtis V. Women are not the same as men: Specific clinical issues for female patients with bipolar disorder // Bipolar Disord. – 2005; 7: 16–24.
13. Fishell A. Depression and Anxiety in Pregnancy // J. Popul. Ther. Clin. Pharmacol. – 2010; 17 (3): e363–e369.
14. Freeman M., Smith K., Freeman S. et al. The impact of reproductive events on the course of bipolar disorder in women // J. Clin. Psychiatry. – 2002; 63: 284–7.
15. Harden C., Pennell P., Koppel B. et al. Practice parameter update: management issues for women with epilepsy–focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society // Neurology. – 2009; 73 (2): 142–9.
16. Hirschfeld R., Calabrese J., Weissman M. et al. Screening for bipolar disorder in the community // J. Clin. Psychiatry. – 2003; 64: 53–9.
17. Horton S, Tuerk A, Cook D et al. Maximum Recommended Dosage of Lithium for Pregnant Women Based on a PBPK Model for Lithium Absorption // Adv. Bioinformatics. – 2012: 352729. Epub. 2012, May 30.
18. Hunt S., Craig J., Morrow J. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy // Neurology. – 2009; 12 (72): 1108.
19. Iqbal M., Gundlapalli S., Ryan W. et al. Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants // South Med. J. – 2001; 94: 304, 135.
20. Jensvold M., Halbreich U. Psychopharmacology and women: sex, gender, and hormones // Am. Psych. Press. – Washington, DC. – 1996; 191–224.
21. Judd L., Akiskal H. The prevalence and disability of bipolar spectrum disorders in the US population: reanalysis of the ECA database taking into account sub-threshold cases // J. J. Affect. Disord. – 2003; 73: 123–31.
22. Kessler R., Chiu W., Demler O. et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication // Arch. Gen. Psychiatry. – 2005; 62: 617–27.
23. Kessler R., McGonagle K., Zhao S. et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey A. Arch. Gen. Psychiatry. – 1994; 51: 8–19.
24. Krishnan K. Psychiatric and medical comorbidities of bipolar disorder // Psychosom. Med. – 2005; 67: 1–8.
25. Llewellyn A., Stowe Z., Strader Jr J. The use of lithium and management of women with bipolar disorder during pregnancy and lactation // J. Clin. Psychiatr. – 1998; 59 (Suppl. 6): 57–64.
26. Lopes R, Fernandes L. Bipolar disorder: clinical perspectives and implications with cognitive dysfunction and dementia // Depress. Res. Treat. – 2012; 275957. Epub. 2012 May 28.
27. Marsh W., Ketter T., Crawford S. et al. Progression of female reproductive stages associated with bipolar illness exacerbation // Bipolar Disord. – 2012; (Epub. ahead of print).
28. Newport D., Stowe Z., Viguera A. et al. Lamotrigine in bipolar disorder: efficacy during pregnancy // Bipolar Disord. – 2008; 10 (3): 432–6.
29. Newport D., Viguera A., Beach A. et al. Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy // Am. J. Psychiatry. – 2005; 162: 2162–70.
30. NICE clinical guideline 38 Bipolar disorder: the management of bipolar disorder in adults, children and adolescents, in primary and secondary care. – 2006.
31. Nivoli A., Pacchiarotti I., Rosa A. et al. Gender differences in a cohort study of 604 bipolar patients: The role of predominant polarity // J. Affect. Disord. – 2011; 133 (3): 443–9.
32. Nonacs R., Cohen L. Postpartum mood disorders: diagnosis and treatment guidelines // J. Clin. Psychiatry.– 1998; 59 (Suppl. 2): 34–40.
33. Sabers A., Ohman I., Christensen J. et al. Oral contraceptives reduce lamotrigine plasma levels reduced by oral contraceptives // Neurol. – 2003; 61: 570–1.
34. Safer D., Zito J., Safer A. Age-grouped differences in bipolar mania. Compr. Psychiatry. – 2012; (Epub. ahead of print).
35. Schatz D., Hsiao M., Liu C. Antenatal depression in East Asia: a review of the literature // Psychiatr. Investig. – 2012; 9 (2): 111–8.
36. Sharma V. Pharmacotherapy of postpartum depression. Expert Opin Pharmacother. – 2002; 3: 1421–31.
37. Stewart D., Klompenhouwer J., Kendall R. et al. Prophylatic lithium in puerperal psychosis: the experience of three centers // Br. J. Psychiatry. – 1991; 158: 393–7.
38. Terp I., Mortensen P. Postpartum psychoses: clinical diagnoses and relative risk of admission after parturition // Br. J. Psychiatry. – 1998; 172: 521–6.
39. Tiet Q., Mausbach B. Treatments for patients with dual diagnosis: a review // Alcohol. Clin. Exp. Res. – 2007; 31(4): 513–36.
40. Viguera A., Cohen L. Bouffard SBA. Reproductive Decisions by Women With Bipolar Disorder After Prepregnancy Psychiatric Consultation // Am. J. Psychiatry. – 2002; 159: 2102–4.
41. Viguera A., Nonacs R., Cohen L. et al. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance // Am. J. Psychiatr. – 2000; 157: 179–84.
42. Viguera A., Whitfield T., Baldessarini R. et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation // Am. J. of Psychiatr. – 2007; 164 (12): 1817–24.
43. Ward S, Wisner L. Collaborative Management of Women with Bipolar Disorder During Pregnancy and Postpartum: Pharmacologic Considerations // J. Midwifer. Wom. Health. – 2007; 52 (1): 3–13.
44. Williams K., Oakes S. Lithium in Pregnancy. – Psychiat. – 2000; 24: 229–31.
45. Wilson S., Nutt D., Alford C. et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders // J. Psychopharmacol. – 2010; 24 (11): 1577–601.
46. Wisner K., Perel J. Ed. M. Jensvold, U. Halbreich. Psychopharmacology and women: sex, gender, and hormones // Am. Psychiatr. Press. – Washington, DC. – 1996; p. 191–224.
47. Yatham L., Kennedy S., Schaffer A. et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009 // Bipolar Disord. – 2009; 11 (3): 225–55.
48. Yerby M. Special considerations for women with epilepsy // Pharmacother. – 2000; 20: 159S–170S.
49. Yonkers K., Wisner K., Stowe Z. et al. Management of bipolar disorder during pregnancy and the postpartum period //Am. J. Psychiatr. – 2004; 161: 608–20.

 

 
Рассылка
Важно

→ Фармакопейные статьи


→ Медицинские архивы на службе современного врача


→ Перечень медицинских технологий

ЭКД архив

 

Баннер
Баннер
Баннер
Информационные партнеры:
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер